Blackstone Life Sciences, which is part of the Blackstone group, has entered a collaboration with French pharmaceutical firm Sanofi, according to a joint press release.
Blackstone will invest EUR 300m with the aim of getting Sanofi’s drug Sarclisa, a treatment of the type of bone marrow cancer known as multiple myeloma, on the market in a subcutaneous formulation, meaning the drug is administered under the skin.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
2 Sales Representatives and Product Specialists 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Clinical Trial Administrator 
Analytical Coordinator for Analytical Development 
(Senior) Drug Substance Specialist 
Senior Chemical Safety Advisor 
Production Director 
Chemist for Incoming Materials in QC Department 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Director Global Engineering 
Industrial Designer- Design Engineer 
Senior Project Manager (GMP - Life Science) 
Project Manager & Scrum Master 
Clinical Project Manager 
Clinical Trial Manager for development of in vitro diagnostics 
Key Account Manager, Europe and Asia